Zazove Associates’s C5 Acquisition Corporation Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share CXAC.WS Stock Holding History
Bought
Maintained
Sold
Other funds holding CXAC.WS
RCM
LP
BFM
SCM
GAM
SCM
LA
AA
PAMP
Zazove Associates's CXAC.WS Position: Q4 2022 in Review
Zazove Associates sold out of C5 Acquisition Corporation Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share (CXAC.WS) in Q4 2022, closing a stake of 108,607 shares — an estimated $12K sold.
Zazove Associates first reported a position in CXAC.WS in Q1 2022 and held it in 2 quarters. The position peaked at $39K in Q1 2022. 43 funds tracked by Wall St. Rank hold CXAC.WS as of Q4 2022.
- Zazove Associates reported no remaining C5 Acquisition Corporation Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share position as of Q4 2022 after selling out during the quarter.
- Zazove Associates sold 108,607 C5 Acquisition Corporation Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share shares in Q4 2022, an estimated $12K.
- Zazove Associates first reported a position in C5 Acquisition Corporation Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share in Q1 2022 and held it in 2 quarters.
- Zazove Associates's C5 Acquisition Corporation Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share position peaked at $39K in Q1 2022.
- 43 funds tracked by Wall St. Rank held C5 Acquisition Corporation Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share as of Q4 2022.
Based on Zazove Associates's 13F filing for Q4 2022, filed 31 Jan 2023.